대장암 진단 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00013454
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 213
Buy Now

[연구보고서] 대장암 진단 시장 규모는 2022년 103억7468만달러에서 2028년 169억9648만달러로 성장할 것으로 예상된다. 2023년부터 2028년까지 8.7%의 CAGR을 기록할 것으로 추정됩니다.

대장암 진단 시장은 양식, 최종 사용자 및 지역을 기준으로 분류됩니다. 이 보고서는 다양한 지역의 주요 시장 참가자에 대한 동인, 추세, 기회 및 경쟁 구도 분석과 같은 매개변수를 강조하면서 통찰력과 심층적인 시장 분석을 제공합니다. 또한 주요 지역에 걸친 코로나19 팬데믹의 영향에 대한 분석도 포함되어 있습니다.

전략적 통찰력

시장 통찰력

신제품 출시로 대장암 성장 촉진

h3>

대장직장암 진단 시장의 주요 업체들은 대장암 및 결장 폴립, 크론병, 대장염, 과민성 대장 증후군과 같은 기타 관련 징후의 부담을 줄이는 데 도움이 되는 다양한 장치를 제조합니다. 2022년 7월, 최고 등급의 위장(GI) 진료 네트워크인 미국 소화기 건강(USDH)은 미국 최대 규모의 Genious 지능형 GI 내시경 모듈 설치를 통해 AI 보조 대장 내시경 검사의 상용화를 발표했습니다. 이 모듈은 의사가 감지하기 어렵고 잠재적으로 암성 폴립을 실시간으로 식별하는 데 도움이 될 것으로 예상됩니다. 이 장치의 출시로 펜실베니아 남동부, 남서부 및 중부 전역의 환자들은 이제 향상된 기능을 갖춘 AI 보조 대장 내시경 검사에 액세스할 수 있습니다. 2020년 9월, Olympus Corporation은 인공 지능(AI)으로 구동되는 최첨단 플랫폼인 ENDO-AID의 출시를 발표했습니다. 플랫폼에는 결장의 다양한 상태를 감지하기 위한 컴퓨터 보조 내시경 방법인 ENDO-AID CADe 애플리케이션(앱)이 포함되어 있습니다. 이 새로운 AI 플랫폼은 자동으로 감지된 의심스러운 병변을 실시간으로 표시하고 EVIS X1과 함께 작동합니다. 따라서 빈번한 개발과 신제품 출시가 대장암 진단 시장 성장을 주도합니다.

양식 기반 통찰력

양식에 기반한 대장암 진단 시장은 대변 기반 테스트와 영상 테스트로 구분됩니다. 2022년에는 영상 테스트 부문이 대장암 진단 시장에서 더 큰 점유율을 차지했으며 예측 기간 동안 더 높은 CAGR을 기록할 것으로 예상됩니다. 대장암 진단에서 영상 검사의 사용은 지난 몇 년 동안 발전해 왔습니다. 영상 결과는 감시, 진단, 병기 설정, 치료 선택 및 후속 조치 일정에 중요한 역할을 합니다. 영상 검사에는 결장과 직장의 구조를 관찰하여 비정상적인 부위가 있는지 살펴봅니다. 영상 검사에서는 끝에 가볍고 작은 비디오 카메라가 달린 튜브형 기구인 내시경을 직장에 삽입하여 사용합니다. 이 검사는 결장과 직장 내부를 검사하여 암이나 폴립일 수 있는 비정상적인 부위가 있는지 검사합니다. 이러한 검사는 대변 기반 검사보다 덜 자주 사용되며 대변 기반 검사와는 달리 사전에 더 많은 준비가 필요하고 일부 관련 위험이 있습니다. 영상검사는 다시 대장내시경, CT 대장조영술, 굴곡성 구불창자내시경, 캡슐내시경 등으로 분류된다.

2022년 대장내시경 부문이 시장에서 가장 큰 점유율을 차지했다. 그러나 CT 대장조영술은 빠른 속도로 성장할 것으로 예상된다. 예측 기간 동안 속도가 더 빨라집니다. CT 대장조영술은 벽 기형의 형태학적 분석을 돕고 대장암의 T 병기 결정에 대한 수술 전 평가에 필요한 정보를 제공합니다. RECIST(고형 종양의 반응 평가 기준) 지침에 따르면 CT는 전이된 결장 및 직장 종양 환자의 치료 반응을 평가하는 데 가장 널리 사용되는 방식입니다. CT 대장조영술의 일반적인 장점은 빠르고 안전하며, 대장 전체를 시각화하는 데 도움이 되고, 검사를 수행하는 데 진정제가 필요하지 않다는 것입니다. 이 검사는 평균 위험도를 지닌 무증상 환자를 대상으로 5년마다 실시하도록 권장됩니다.

대장암 진단 시장, 방식별 – 2022~2028

최종 사용자 기반 통찰력

최종 사용자를 기준으로 대장암 진단 시장은 병원, 진단 실험실, 암 연구 기관 등으로 분류됩니다. 병원 부문은 2022년 가장 큰 시장 점유율을 차지했으며 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.

대장암 진단 시장 참여자는 제품 출시 및 확장과 같은 유기적 전략을 채택하여 시장을 확대합니다. 지리적 공간 및 제품 포트폴리오를 확보하고 증가하는 수요를 충족합니다. 시장 참가자가 채택한 무기 성장 전략을 통해 비즈니스를 확장하고 지리적 입지를 강화할 수 있습니다. 또한 이러한 성장 전략은 기업이 고객층을 강화하고 제품 포트폴리오를 확대하는 데 도움이 됩니다.

  • 2022년 12월 Epigenomics는 혈액 기반 대장암 검사를 위한 단백질 바이오마커 기술 라이선스를 취득했습니다. 이 회사는 텍사스 대학교 MD 앤더슨 암 센터로부터 대장암 발견과 관련된 바이오마커에 대한 특정 특허 및 기술 권리를 허가 받았습니다.
  • 2021년 8월, Illumina는 환자의 삶에 대한 접근을 가속화하기 위해 GRAIL을 인수했습니다. 다발암 조기진단검사 저장. GRAIL의 Galleri 혈액 검사는 증상이 나타나기 전에 50가지의 다양한 암을 감지합니다. Illumina의 GRAIL 인수로 전 세계적으로 이 생명을 구하는 테스트에 대한 액세스와 채택이 가속화될 것입니다.

회사 프로필

  • Medtronic Plc
  • Illumina Inc
  • Clinical Genomics Technologies Pty Ltd
  • EDP Biotech Corp
  • Epigenomics AG
  • F. Hoffmann-La Roche Ltd
  • Quest Diagnostics Inc
  • Novigenix SA
  • Siemens Healthineers AG
  • Bruker Corp
  • 에이켄화학(주)
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the colorectal cancer diagnostics market across the globe?

The factors that are driving growth of the market are increasing prevalence of colorectal cancer and launches of new products.

Which country is dominated the colorectal cancer diagnostics market?

The US holds the largest market share in colorectal cancer diagnostics market. The growth of the market in the country is because in 2022, more than 600,000 surgeries are performed annually in the US to treat colon diseases. According to the American Cancer Society, the 5-year survival rate for localized colon cancer is 91% and for localized rectal cancer is 90%.

Who are the major players in the colorectal cancer diagnostics market?

The colorectal cancer diagnostics market majorly consists of the players such as Medtronic Plc, Illumina Inc, Clinical Genomics Technologies Pty Ltd, EDP Biotech Corp, Epigenomics AG, F Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Novigenix SA, Siemens Healthineers AG, Bruker Corp, and Eiken Chemical Co Ltd.

What is colorectal cancer diagnostics?

Colorectal cancer diagnostics refers to the tools, kits and test performed on an individual to diagnose colorectal cancer in an individual. This involves series of non-invasive and invasive test to confirm the cancer and its stage based on that treatment will be provided to the patient.

Which region is the fastest-growing the colorectal cancer diagnostics market?

Asia Pacific is expected to be the fastest growing region in the colorectal cancer diagnostics market. Asia Pacific registered as the fastest-growing region in the global colorectal cancer diagnostics market. The market in this region is driven due to rising incidences of colorectal cancer, easy access to the diagnosis for colorectal cancer, and proposing guidelines for the procedures. Also, increasing government funding for research activities in colorectal cancer is expected to propel the growth of the market for colorectal cancer diagnostics in Asia Pacific.

Which segment is dominating the colorectal cancer diagnostics market?

The colorectal cancer diagnostics market, based on modality, is bifurcated into imaging tests and stool based tests. In 2022, the imaging tests segment held the larger share and is expected to grow at a CAGR of 8.8% during the forecast period. Screening and imaging play a vital role in the diagnostics of colorectal cancer to understand the extent of tumor-affected area, that act as a major driving factor for the growth of the imaging tests segment.

The List of Companies - Colorectal Cancer Diagnostics Market

  1. Medtronic Plc
  2. Illumina Inc
  3. Clinical Genomics Technologies Pty Ltd
  4. EDP Biotech Corp
  5. Epigenomics AG
  6. F. Hoffmann-La Roche Ltd
  7. Quest Diagnostics Inc
  8. Novigenix SA
  9. Siemens Healthineers AG
  10. Bruker Corp
  11. Eiken Chemical Co., Ltd.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports